Investors are plunking billions of dollars into AI-focused biopharma companies—a more than 300% increase from 2023
Investors put $5.6 billion into such companies, which develop drugs made of biological sources like vaccines.
Businesses are beefing up insurance to ease the burden of devastating wildfires—but it’s not cheap
More businesses are turning to a nontraditional coverage option called parametrics to beef up protection against wildfire ...
Traders are moving so much gold from the Bank of England to the U.S. to avoid Trump tariffs that the waiting time has reportedly octupled
Investors are reportedly waiting up to eight weeks to unlock their gold and ship it to the U.S.